Nektar Therapeutics Down Nearly 21%, on Pace for Largest Percent Decrease Since February 2023 -- Data Talk

Nektar Therapeutics (NKTR) is currently at $47.86, down $12.68 or 20.94%

--Would be lowest close since Feb. 9, 2026, when it closed at $37.07

--On pace for largest percent decrease since Feb. 24, 2023, when it fell 49.66%

--Currently down three of the past five days

--Up 13.21% year-to-date

--Down 97.06% from its all-time closing high of $1626.60 on March 8, 2018

--Down 20.88% from 52 weeks ago (Oct. 2, 2025), when it closed at $60.50

--Down 52.3% from its 52-week closing high of $100.35 on April 20, 2026

--Up 36.29% from its 52-week closing low of $35.12 on Feb. 5, 2026

--Traded as low as $47.15; lowest intraday level since Feb. 10, 2026, when it hit $47.05

--Down 22.12% at today's intraday low; largest intraday percent decrease since Feb. 24, 2023, when it fell as much as 50.68%

All data as of 12:09:43 PM ET

Source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

October 01, 2026 12:12 ET (16:12 GMT)